The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
Open Access
- 1 January 2020
- journal article
- review article
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 12 (1) , e12065
Abstract
Introduction Adults with Down syndrome (DS) are at exceptionally high risk for Alzheimer's disease (AD), with virtually all individuals developing key neuropathological features by age 40. Identifying biomarkers of AD progression in DS can provide valuable insights into pathogenesis and suggest targets for disease modifying treatments. Methods We describe the development of a multi‐center, longitudinal study of biomarkers of AD in DS. The protocol includes longitudinal examination of clinical, cognitive, blood and cerebrospinal fluid‐based biomarkers, magnetic resonance imaging and positron emission tomography measures (at 16‐month intervals), as well as genetic modifiers of AD risk and progression. Results Approximately 400 individuals will be enrolled in the study (more than 370 to date). The methodological approach from the administrative, clinical, neuroimaging, omics, neuropathology, and statistical cores is provided. Discussion This represents the largest U.S.‐based, multi‐site, biomarker initiative of AD in DS. Findings can inform other multidisciplinary networks studying AD in the general population.Keywords
Funding Information
- National Institute on Aging
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 85 references indexed in Scilit:
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 2011
- A Serum Protein–Based Algorithm for the Detection of Alzheimer DiseaseArchives of Neurology, 2010
- Neuroimaging of individuals with Down’s syndrome at-risk for dementia: Evidence for possible compensatory eventsNeuroImage, 2008
- Chapter 4 Alzheimer's Disease in Adults with Down Syndrome2008
- APP locus duplication in a Finnish family with dementia and intracerebral haemorrhageJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated PedigreesJournal of Neuroscience, 2007
- Cholesterol level, statin use and Alzheimer's disease in adults with Down syndromeNeuroscience Letters, 2007
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- The Neuropsychiatric InventoryNeurology, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958